Stand Up for Science traces the decades-long science behind mRNA vaccines

Stand Up for Science’s latest “Traces Thursday” installment follows the research path that made COVID-19 mRNA vaccines possible, showing how decades of basic science enabled a rapid pandemic response. The piece also argues that sustained federal research funding is essential for future medical breakthroughs.

Why it matters: - The COVID-19 vaccines were developed in under a year, but the mRNA platform depended on about 40 years of research. - The story highlights how long-term basic and biomedical research can translate into fast-moving public health tools during a crisis. - The installment comes as debate continues over federal science funding.

What happened: - Stand Up for Science released the 11th installment of its weekly “Traces Thursday” series. - The latest story, “COVID-19 and Sars-CoV-2,” explains the scientific roots of mRNA vaccines and how those roots helped bring the pandemic under control. - Stand Up for Science said the next installment will publish on Thursday on the Science Fight Club Substack.

The details: - Most vaccines work by exposing the body to an active virus that cannot replicate or an attenuated virus that can replicate without causing major illness. - mRNA vaccines use messenger RNA, which carries instructions to the cell’s protein-making machinery. - Instead of delivering a virus or lab-made protein, an mRNA vaccine gives cells instructions to build a harmless piece of the virus and train the immune system. - A virus’s genetic sequence is enough to start designing an mRNA vaccine. - In the late 1980s, researchers were already exploring the concept, but mRNA was known to be fragile and easy to break down. - Research in the 2000s showed how to modify mRNA to avoid an unwanted non-specific immune response. - Several companies were working on mRNA vaccine technology when COVID-19 emerged. - Chinese scientists shared the SARS-CoV-2 genetic sequence early in the pandemic, allowing vaccine design to begin without first growing the virus in a lab. - Dr. Jeremy Berg, author of the Traces series and former director of the National Institute of General Medical Sciences at NIH, said the vaccine was developed and tested in less than one year and showed strong protection with few significant side effects. - Berg said the mRNA vaccine prevented tens of millions of deaths and hundreds of millions of hospitalizations worldwide. - Berg said mRNA vaccines can be reprogrammed relatively easily to target new variants. - Berg said the vaccines were updated as new COVID-19 variants emerged. - The story says mRNA vaccines are not gene therapy and do not modify DNA. - The mRNA does not become part of a person’s DNA, and the viral machinery needed for that process is not present in the vaccines.

Between the lines: - The article frames the COVID-19 vaccine rollout as a case study in why slow, incremental research matters. - It argues that breakthroughs often depend on work that spans far longer than a single grant cycle or presidential administration. - The piece also tries to counter lingering confusion about how mRNA vaccines work.

What's next: - Stand Up for Science plans to continue the weekly series with another installment on Thursday. - Berg is available for comment. - The group says the series will keep focusing on the long research timelines behind major medical advances.

The bottom line: - The mRNA vaccine story is not just about pandemic speed. It is also a reminder that rapid innovation usually rests on decades of patient science.